Award

Targeting vascular dysfunction to promote lung repair and fibrosis resolution

Description: NARRATIVE Idiopathic Pulmonary Fibrosis (IPF) is a chronic, fatal disease of aging with currently limited therapeutic options. This proposal is designed to study the hypothesis that dysfunction of the pulmonary vasculature plays a critical role in the progression of lung fibrosis. Experiments of this grant will investigate the contribution of molecular abnormalities we have discovered in the lung vasculature toward our long term goal of identifying novel targets for the treatment of IPF.
Funding type: research
Funder scheme: R01
Start date: 2022-03-05
End date: 2027-02-28
Investigator: GIOVANNI LIGRESTI
Institution: BOSTON UNIVERSITY MEDICAL CAMPUS
Funded outputs count: 13
Funder award ID: R01HL158733
OpenAlex ID: G9000913182
2026 · Giuseppe Muscato, Benjamin B. Roos, et al. · JCI Insight · 1
2025 · Mehmed T Dinc, Fatima El-Adili, et al. · Journal of Scleroderma and Related Disorders · 3
2025 · Fiorenza Gianì, Benjamin B. Roos, et al. · American Journal of Physiology-Cell Physiology · 6
2024 · Jeongmin Hong, Tho X. Pham, et al. · American Journal of Respiratory Cell and Molecular Biology · 14
2024 · Ahmed A. Raslan, Tho X. Pham, et al. · Nature Communications · 91
2023 · Rohin Banerji, Gabrielle N. Grifno, et al. · Nature Methods · 26
2023 · Jiurong Liang, Giovanni Ligresti · American Journal of Respiratory Cell and Molecular Biology · 8
2023 · Nunzia Caporarello, Giovanni Ligresti · American Journal of Respiratory Cell and Molecular Biology · 38
2023 · Giovanni Ligresti, Ahmed A. Raslan, et al. · Gene · 41
2022 · Kalpana R. Betageri, Patrick A. Link, et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 14
2022 · Domenico Ribatti, Giovanni Ligresti, et al. · Vascular Pharmacology · 11
2022 · Nunzia Caporarello, Jisu Lee, et al. · Nature Communications · 94
Year
Topic